ZEMPLAR Side Effects

6836559-4 | Dysgeusia, Ill-defined Disorder, Pharyngitis, Staphylococcal Bacteraemia
on Jul 09, 2010 Female patient from SPAIN , 46 years of age, was diagnosed with hyperparathyroidism secondary, diabetes mellitus and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, ill-defined disorder, pharyngitis, staphylococcal bacteraemia. Zemplar dosage: . During the same period patient was treated with HIDROXIL (View Hidroxil Review and Hidroxil Label ), ISCOVER (View Iscover Review and Iscover Label ), COZAAR (View Cozaar Review and Cozaar Label ), COROPRESS (View Coropress Review and Coropress Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOCOR (View Zocor Review and Zocor Label ), LEXATIN (View Lexatin Review and Lexatin Label ). Patient was hospitalized.

6836421-7 | Angiopathy, Gangrene
Patient was taking Zemplar (View Usage). Patient had the following side effects: angiopathy, gangrene on Jul 05, 2010 from GREECE Additional patient health information: Male patient , 65 years of age, weighting 210.5 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, hyperphosphataemia, hyperuricaemia and. Zemplar dosage: . During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), VENOFER (View Venofer Review and Venofer Label ), NEUROBION (View Neurobion Review and Neurobion Label ), SUPERAMINE (View Superamine Review and Superamine Label ), RENVELA (3 In Am, 4 Noon, 4 Evening) (View Renvela Review and Renvela Label ), FILICINE (View Filicine Review and Filicine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6828173-1 | Pulmonary Oedema
Adverse event was reported on Jul 08, 2010 by a Female patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: GREECE , weighting 242.5 lb, After Zemplar was administered, patient had the following side effects: pulmonary oedema. During the same period patient was treated with RENAGEL (View Renagel Review and Renagel Label ), MIRCERA (View Mircera Review and Mircera Label ), CALCIORAL (View Calcioral Review and Calcioral Label ). Patient was hospitalized.

6822746-8 | Pulmonary Oedema
on Jun 30, 2010 Female patient from GREECE , weighting 242.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema. Zemplar dosage: . During the same period patient was treated with RENAGEL (View Renagel Review and Renagel Label ), MIRCERA (View Mircera Review and Mircera Label ), CALCIORAL (View Calcioral Review and Calcioral Label ). Patient was hospitalized.


6822518-4 | Cerebrovascular Accident
on Jun 29, 2010 Male patient from GERMANY , weighting 212.7 lb, was treated with Zemplar (View Usage). Patient had the following side effects: cerebrovascular accident. Zemplar dosage: . During the same period patient was treated with NEPHROTRANS (Twice Per Day) (View Nephrotrans Review and Nephrotrans Label ), MICERA (Once Per Month) (View Micera Review and Micera Label ).

6820406-0 | Muscle Abscess, Staphylococcal Sepsis
Patient was taking Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: muscle abscess, staphylococcal sepsis on Jun 28, 2010 from AUSTRIA Additional patient health information: Male patient , weighting 203.9 lb, was diagnosed with hyperparathyroidism and. Zemplar dosage: . Patient was hospitalized.

6815718-0 | Cerebral Haemorrhage
Adverse event was reported on Jun 23, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary, blood phosphorus increased, renal failure and. Location: GERMANY , 58 years of age, weighting 162.0 lb, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. During the same period patient was treated with PHOSPHASORB (View Phosphasorb Review and Phosphasorb Label ), VITAMIN D AND ANALOGUES (View Vitamin D And Analogues Review and Vitamin D And Analogues Label ).

6815714-3 | Cerebrovascular Accident, Fall, Haematoma
on Jun 22, 2010 Female patient from UNITED STATES , weighting 160.1 lb, was diagnosed with renal impairment, heart rate increased, hypothyroidism, fluid retention, anxiety (What is anxiety?), back pain (What is back pain?) and was treated with Zemplar (View Usage). Patient had the following side effects: cerebrovascular accident, fall (What is fall?), haematoma. Zemplar dosage: . During the same period patient was treated with VITAMINS (View Vitamins Review and Vitamins Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), XANAX (View Xanax Review and Xanax Label ), VICODIN (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

6815676-9 | Dyspnoea, Fatigue, Renal Failure
on Jun 30, 2010 Male patient from UNITED STATES , weighting 170.2 lb, was diagnosed with renal failure, renal disorder, blood cholesterol increased, hypertension and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: dyspnoea, fatigue, renal failure. Zemplar dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6815146-8 | Shunt Thrombosis
Patient was taking Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: shunt thrombosis on Jun 24, 2010 from AUSTRIA Additional patient health information: Male patient , 63 years of age, weighting 138.9 lb, was diagnosed with hyperparathyroidism and. Zemplar dosage: . During the same period patient was treated with EPOETIN (View Epoetin Review and Epoetin Label ), FERRLECIT (View Ferrlecit Review and Ferrlecit Label ), MULTIVIT B (View Multivit B Review and Multivit B Label ), ACEMIN (View Acemin Review and Acemin Label ), NOMEXOR (View Nomexor Review and Nomexor Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

6813794-2 | Aortic Valve Disease, Aortic Valve Disease Mixed, Blood Pressure Decreased, Chills, Coronary Artery Disease, Dyspnoea, Emphysema, Enterococcal Infection, Hypertension
Adverse event was reported on Jun 21, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with renal failure, hypertension, coronary artery disease (What is coronary artery disease?) and. Location: GERMANY , 69 years of age, weighting 172.0 lb, Patient had the following side effects: aortic valve disease, aortic valve disease mixed, blood pressure decreased, chills, coronary artery disease (What is coronary artery disease?), dyspnoea, emphysema, enterococcal infection, hypertension. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PENTALONG 80 (View Pentalong 80 Review and Pentalong 80 Label ), MOLSIDOMIN (View Molsidomin Review and Molsidomin Label ), CARVEDILOL (2 Tablets Daily) (View Carvedilol Review and Carvedilol Label ), DIOVAN 160 (1 Tablet Daily) (View Diovan 160 Review and Diovan 160 Label ). Patient was hospitalized.

6813507-4 | Acute Myocardial Infarction
on Jun 24, 2010 Female patient from AUSTRIA , 33 years of age, weighting 132.3 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: acute myocardial infarction. Zemplar dosage: . During the same period patient was treated with RENACET (View Renacet Review and Renacet Label ), ETALPHA (View Etalpha Review and Etalpha Label ), CENIPRES (20/40mg Per Day) (View Cenipres Review and Cenipres Label ), MOXONIBENE (View Moxonibene Review and Moxonibene Label ), NEPHROTRANS (View Nephrotrans Review and Nephrotrans Label ), NOMEXOR (View Nomexor Review and Nomexor Label ), VENOFER (40mg/ml Per Week) (View Venofer Review and Venofer Label ). Patient was hospitalized.

6810653-6 | Atrial Fibrillation, Body Temperature Increased, Confusional State, Dehydration, Fall, Flushing, Head Injury, Laceration, Pneumonia
on Jun 29, 2010 Male patient from UNITED STATES , 79 years of age, weighting 136.0 lb, was diagnosed with neoplasm malignant and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), body temperature increased, confusional state, dehydration, fall (What is fall?), flushing, head injury, laceration, pneumonia (What is pneumonia?). Zemplar dosage: 1 Mcg Qd Po. Patient was hospitalized.

6810645-7 | Humerus Fracture, Radius Fracture, Retroperitoneal Haematoma, Rib Fracture, Ulna Fracture
Patient was taking Zemplar (View Usage). Patient had the following side effects: humerus fracture, radius fracture, retroperitoneal haematoma, rib fracture, ulna fracture on Jun 21, 2010 from AUSTRIA Additional patient health information: Female patient , 57 years of age, weighting 196.2 lb, was diagnosed with hyperparathyroidism and. Zemplar dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LASIX (View Lasix Review and Lasix Label ), NOVOMIX (View Novomix Review and Novomix Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), DIGIMERCK (View Digimerck Review and Digimerck Label ), ACEMIN (View Acemin Review and Acemin Label ), CONCOR (View Concor Review and Concor Label ), FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

6795422-8 | Cardiac Failure, Cerebrovascular Accident, Contusion, Fall, Head Injury, Rib Fracture
Adverse event was reported on Jun 17, 2010 by a Female patient taking Zemplar (View Usage) (Dosage: 5-7 Mcg 3 Times A Week) was diagnosed with hyperparathyroidism secondary and. Location: CROATIA (local name: Hrvatska) , 72 years of age, After Zemplar was administered, patient had the following side effects: cardiac failure, cerebrovascular accident, contusion, fall (What is fall?), head injury, rib fracture. During the same period patient was treated with RENAGEL (800mg;1600mg;800mg) (View Renagel Review and Renagel Label ), DECORTIN (View Decortin Review and Decortin Label ), PHYSIOTENS (View Physiotens Review and Physiotens Label ), AMONEX (View Amonex Review and Amonex Label ), OIKAMID (400-600mg (1 Or 2 Capsules A Day)) (View Oikamid Review and Oikamid Label ), CORYOL (1x1 Tbl, 12.5 Mg Daily Dose) (View Coryol Review and Coryol Label ), MOVALLS (View Movalls Review and Movalls Label ). Patient was hospitalized.

6775732-0 | Asthenia, Cellulitis, Fungal Skin Infection, Thrombosis
on Jun 07, 2010 Female patient from UNITED STATES , weighting 280.3 lb, was diagnosed with renal impairment, hyperparathyroidism secondary, pain (What is pain?), hypertension, gastrooesophageal reflux disease and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cellulitis (What is cellulitis?), fungal skin infection, thrombosis. Zemplar dosage: 2 Mcg On Even Days, 1 Mcg On Odd Days. During the same period patient was treated with LASIX (80 Mg Daily) (View Lasix Review and Lasix Label ), DARVON (View Darvon Review and Darvon Label ), DIOVAN (View Diovan Review and Diovan Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

6766946-4 | Concussion, Skull Fracture, Subarachnoid Haemorrhage, Traumatic Brain Injury
on Jun 11, 2010 Male patient from GERMANY , weighting 149.9 lb, was diagnosed with hyperparathyroidism secondary, hypertension, renal failure, anaemia and was treated with Zemplar (View Usage). Patient had the following side effects: concussion (What is concussion?), skull fracture, subarachnoid haemorrhage, traumatic brain injury (What is traumatic brain injury?). Zemplar dosage: . During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), RENAGEL (View Renagel Review and Renagel Label ), ARANESP (View Aranesp Review and Aranesp Label ).

6764850-9 | Coronary Artery Occlusion, Myocardial Infarction
Patient was taking Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: coronary artery occlusion, myocardial infarction on May 31, 2010 from GERMANY Additional patient health information: Male patient , weighting 142.2 lb, was diagnosed with hyperparathyroidism secondary, blood phosphorus increased, renal failure, anaemia, hypertension, hypothyroidism, hypercholesterolaemia and. Zemplar dosage: . During the same period patient was treated with CA ACETATE (View Ca Acetate Review and Ca Acetate Label ), PHOSPHONORM (View Phosphonorm Review and Phosphonorm Label ), ARANESP (View Aranesp Review and Aranesp Label ), EXFORGE (5/160 Mg) (View Exforge Review and Exforge Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SIMVAHEXAL (View Simvahexal Review and Simvahexal Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ).

6764496-2 | Haemodialysis-induced Symptom, Renal Failure Chronic
Adverse event was reported on Jun 08, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with nephropathy, renal failure, oxygen supplementation, rheumatoid arthritis (What is rheumatoid arthritis?), arthralgia, cardiac disorder and. Location: UNITED STATES , weighting 115.1 lb, Patient experienced the following unwanted or unexpected effects: haemodialysis-induced symptom, renal failure chronic. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), REMICADE (View Remicade Review and Remicade Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COREG (View Coreg Review and Coreg Label ), REMERON (View Remeron Review and Remeron Label ).

6764495-0 | Concussion, Skull Fractured Base, Subarachnoid Haemorrhage, Traumatic Brain Injury
on May 31, 2010 Male patient from GERMANY , weighting 149.9 lb, was diagnosed with hyperparathyroidism secondary, hypertension, renal failure, anaemia and was treated with Zemplar (View Usage). Patient had the following side effects: concussion (What is concussion?), skull fractured base, subarachnoid haemorrhage, traumatic brain injury (What is traumatic brain injury?). Zemplar dosage: . During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), RENAGEL (View Renagel Review and Renagel Label ), ARANESP (View Aranesp Review and Aranesp Label ).

6762147-4 | Acute Respiratory Failure, Communication Disorder, Cyanosis, Dyspnoea, Hypercalcaemia, Hypercapnia, Respiratory Tract Infection
on May 31, 2010 Female patient from , weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia, hypercalcaemia, thrombosis prophylaxis, osteoporosis (What is osteoporosis?), dyslipidaemia, vitamin supplementation, hypertension, anaemia and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: acute respiratory failure, communication disorder, cyanosis, dyspnoea, hypercalcaemia, hypercapnia, respiratory tract infection. Zemplar dosage: . During the same period patient was treated with RENAGEL (2 Capsules In Am; 3 Capsules At Noon; 2 Capsules In The Pm) (View Renagel Review and Renagel Label ), CINACALCET HYDROCHLORIDE (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ), ISCOVER (View Iscover Review and Iscover Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), LEPUR (View Lepur Review and Lepur Label ), FILICINE (View Filicine Review and Filicine Label ), AMLOPEN (View Amlopen Review and Amlopen Label ), RETACRIT (View Retacrit Review and Retacrit Label ). Patient was hospitalized.

6759056-3 | Asthenia, Coronary Artery Occlusion, Fall, Loss Of Consciousness, Oedema Peripheral, Pollakiuria, Syncope, Thrombosis, Urinary Incontinence
Patient was taking Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, coronary artery occlusion, fall (What is fall?), loss of consciousness, oedema peripheral, pollakiuria, syncope, thrombosis, urinary incontinence (What is urinary incontinence?) on May 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 135.1 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary, blood calcium increased, medical diet, gastrooesophageal reflux disease and. Zemplar dosage: . During the same period patient was treated with VITAMIN D (50,000u Two A Month) (View Vitamin D Review and Vitamin D Label ), CALCITONIN SALMON (Alternates Nostrils Every Other Day) (View Calcitonin Salmon Review and Calcitonin Salmon Label ), PLAVIX (View Plavix Review and Plavix Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ZANTAC (View Zantac Review and Zantac Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6757126-7 |
Adverse event was reported on May 28, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with renal failure chronic, hyperparathyroidism secondary and. Location: GERMANY , weighting 159.8 lb, .

6756983-8 | Gastrointestinal Haemorrhage
on May 26, 2010 Female patient from PERU , weighting 95.90 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: gastrointestinal haemorrhage. Zemplar dosage: 22.4 Mcg 3 Vig.

6756857-2 | Cellulitis
on May 26, 2010 Male patient from PERU , weighting 103.6 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?). Zemplar dosage: . Patient was hospitalized.

6752453-1 | Colitis
Patient was taking Zemplar (View Usage). Patient had the following side effects: colitis on May 28, 2010 from GERMANY Additional patient health information: Female patient , 86 years of age, weighting 153.2 lb, was diagnosed with hyperparathyroidism, iron deficiency, platelet aggregation inhibition, mineral supplementation, hypertension, hypercholesterolaemia and. Zemplar dosage: . During the same period patient was treated with RETACRIT (View Retacrit Review and Retacrit Label ), FERRLECIT (View Ferrlecit Review and Ferrlecit Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CARENAL (View Carenal Review and Carenal Label ), CARMEN (View Carmen Review and Carmen Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6748014-0 | Dyspnoea, Lip Swelling, Pharyngeal Oedema
Adverse event was reported on May 24, 2010 by a Female patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with renal impairment and. Location: UNITED STATES , weighting 220.2 lb, After Zemplar was administered, patient had the following side effects: dyspnoea, lip swelling, pharyngeal oedema.

6747840-1 | Cellulitis
on May 26, 2010 Male patient from PERU , weighting 103.6 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?). Zemplar dosage: . Patient was hospitalized.

6747839-5 | Glaucoma
on May 19, 2010 Male patient from GERMANY , 83 years of age, weighting 174.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). Patient had the following side effects: glaucoma (What is glaucoma?). Zemplar dosage: . Patient was hospitalized.

6744988-2 | Arrhythmia, Dyspnoea, Palpitations, Pericardial Effusion
Patient was taking Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), dyspnoea, palpitations, pericardial effusion on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 115.1 lb, was diagnosed with nephropathy, hypertension and. Zemplar dosage: Doesn't Remember Dose. During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ). Patient was hospitalized.

6742766-1 | Blood Calcium Increased
Adverse event was reported on Mar 11, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism and. Location: UNITED STATES , 74 years of age, Patient experienced the following unwanted or unexpected effects: blood calcium increased.

6742765-X | Asthenia, Fall, Feeling Abnormal, Memory Impairment, Nausea, Yawning
on Apr 09, 2010 Female patient from UNITED STATES , weighting 206.2 lb, was diagnosed with renal disorder and was treated with Zemplar (View Usage). Patient had the following side effects: asthenia, fall (What is fall?), feeling abnormal, memory impairment, nausea (What is nausea?), yawning. Zemplar dosage: . During the same period patient was treated with MULTIPLE UNLISTED CONCOMITANTS (View Multiple Unlisted Concomitants Review and Multiple Unlisted Concomitants Label ).

6742764-8 | Constipation
on May 05, 2010 Female patient from UNITED STATES , weighting 190.2 lb, was diagnosed with renal failure, cardiac disorder, constipation prophylaxis, prophylaxis against gastrointestinal ulcer and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: constipation (What is constipation?). Zemplar dosage: . During the same period patient was treated with RANEXA (2-500mg Tablets Every Two Days) (View Ranexa Review and Ranexa Label ), NEURONTIN (Daily) (View Neurontin Review and Neurontin Label ), LOPID (View Lopid Review and Lopid Label ), COLACE (2-100mg Tablets Daily) (View Colace Review and Colace Label ), ZYLOPRIM (View Zyloprim Review and Zyloprim Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROCARDIA (View Procardia Review and Procardia Label ), PEPCID (View Pepcid Review and Pepcid Label ).

6742760-0 | Asthenia, Bone Pain
Patient was taking Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bone pain on Apr 26, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 159.1 lb, was diagnosed with vitamin d deficiency, depression (What is depression?) and. Zemplar dosage: . During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), NATURAL SUPPLEMENTS (View Natural Supplements Review and Natural Supplements Label ).

6742756-9 | Blood Magnesium Abnormal
Adverse event was reported on Apr 05, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with renal failure and. Location: UNITED STATES , weighting 165.3 lb, Patient had the following side effects: blood magnesium abnormal. During the same period patient was treated with FOSRENOL (View Fosrenol Review and Fosrenol Label ).

6742754-5 | Musculoskeletal Stiffness, Myalgia
on May 10, 2010 Female patient from UNITED STATES , 85 years of age, was diagnosed with blood creatinine increased, vitamin d decreased and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: musculoskeletal stiffness, myalgia. Zemplar dosage: .

6742747-8 | Herpes Zoster, Malaise
on Feb 19, 2010 Female patient from UNITED STATES , 82 years of age, weighting 175.2 lb, was diagnosed with renal disorder, arthritis (What is arthritis?), hypertension, hypothyroidism, vitamin supplementation and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: herpes zoster, malaise. Zemplar dosage: . During the same period patient was treated with ACETAMINOPHEN W/ PROPOXYPHENE HCL (View Acetaminophen W/ Propoxyphene Hcl Review and Acetaminophen W/ Propoxyphene Hcl Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), VITAL D (View Vital D Review and Vital D Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6742746-6 | Asthenia, Blood Calcium Increased, Haemoglobin Decreased, Myalgia
Patient was taking Zemplar (View Usage). Patient had the following side effects: asthenia, blood calcium increased, haemoglobin decreased, myalgia on Nov 09, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 150.1 lb, was diagnosed with renal failure chronic, anaemia, hypertension and. Zemplar dosage: . During the same period patient was treated with PROCRIT (View Procrit Review and Procrit Label ), IRON (View Iron Review and Iron Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), HCTZ (View Hctz Review and Hctz Label ).

6742745-4 | Asthenia, Fatigue, Headache, Nausea
Adverse event was reported on Jan 19, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with renal failure, blood parathyroid hormone increased, hypertension, diabetes mellitus, blood cholesterol increased, hypothyroidism and. Location: UNITED STATES , weighting 215.2 lb, After Zemplar was administered, patient had the following side effects: asthenia, fatigue, headache (What is headache?), nausea (What is nausea?). During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), ZETIA (View Zetia Review and Zetia Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6742744-2 | Blood Phosphorus Decreased, Vitamin D Decreased
on Feb 19, 2010 Female patient from UNITED STATES , 86 years of age, weighting 130.1 lb, was diagnosed with renal failure and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: blood phosphorus decreased, vitamin d decreased. Zemplar dosage: . During the same period patient was treated with PROCRIT (View Procrit Review and Procrit Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6742742-9 | Blood Potassium Increased, Weight Decreased
on Feb 11, 2010 Male patient from UNITED STATES , weighting 195.2 lb, was diagnosed with renal disorder, blood creatine abnormal and was treated with Zemplar (View Usage). Patient had the following side effects: blood potassium increased, weight decreased. Zemplar dosage: . During the same period patient was treated with KAYEXALATE (View Kayexalate Review and Kayexalate Label ).

6742741-7 | Nasopharyngitis
Patient was taking Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: nasopharyngitis on Mar 05, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 230.2 lb, . Zemplar dosage: .

6742737-5 | Memory Impairment, Tremor
Adverse event was reported on Nov 09, 2009 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with nephropathy, gastrooesophageal reflux disease, constipation (What is constipation?), hypothyroidism, hypertension, blood potassium decreased and. Location: UNITED STATES , weighting 140.1 lb, Patient experienced the following unwanted or unexpected effects: memory impairment, tremor. During the same period patient was treated with ZEGERID (View Zegerid Review and Zegerid Label ), AMITIZA (View Amitiza Review and Amitiza Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), COUMADIN (View Coumadin Review and Coumadin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

6742736-3 | Alopecia, Gastric Disorder
on Jan 20, 2010 Female patient from UNITED STATES , weighting 195.2 lb, was diagnosed with hypoparathyroidism, blood cholesterol increased, hypertension, depression (What is depression?), urinary incontinence (What is urinary incontinence?) and was treated with Zemplar (View Usage). Patient had the following side effects: alopecia, gastric disorder. Zemplar dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), DIOVAN (View Diovan Review and Diovan Label ), CELEXA (View Celexa Review and Celexa Label ), OXYBUTYNIN CHRLORIDE (View Oxybutynin Chrloride Review and Oxybutynin Chrloride Label ).

6742735-1 | Anaemia, Blood Urine Present, Dysuria, Urinary Tract Infection
on Mar 03, 2010 Male patient from UNITED STATES , weighting 220.2 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary, nephropathy, mineral supplementation, constipation prophylaxis, hypertension and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: anaemia, blood urine present, dysuria, urinary tract infection (What is urinary tract infection?). Zemplar dosage: . During the same period patient was treated with SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), TUMS EX (View Tums Ex Review and Tums Ex Label ), DOCUSATE (View Docusate Review and Docusate Label ), LABETALOL HCL (1.5 Tabs Bid) (View Labetalol Hcl Review and Labetalol Hcl Label ).

6742733-8 | Dyspnoea
Patient was taking Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea on Oct 12, 2009 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with renal failure chronic and. Zemplar dosage: .

6742725-9 | Fatigue, Musculoskeletal Pain, Pain In Extremity
Adverse event was reported on Nov 02, 2009 by a Female patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with malabsorption, hypovitaminosis, gout (What is gout?), blood cholesterol increased, pain (What is pain?), depression (What is depression?), hypertension and. Location: UNITED STATES , weighting 179.2 lb, Patient had the following side effects: fatigue, musculoskeletal pain, pain in extremity. During the same period patient was treated with VITAMIN D (View Vitamin D Review and Vitamin D Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), DARVOCET (View Darvocet Review and Darvocet Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

6742724-7 | Abdominal Distension, Diarrhoea, Flatulence, Gastrointestinal Disorder
on Sep 23, 2009 Male patient from UNITED STATES , weighting 167.6 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: abdominal distension, diarrhoea, flatulence, gastrointestinal disorder. Zemplar dosage: .

6742723-5 | Hypercalcaemia
on Mar 11, 2010 Male patient from UNITED STATES , 30 years of age, was diagnosed with renal transplant and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: hypercalcaemia. Zemplar dosage: .

6742722-3 | Asthenia, Dysphonia, Pruritus
Patient was taking Zemplar (View Usage). Patient had the following side effects: asthenia, dysphonia, pruritus on Dec 09, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with hyperparathyroidism, dialysis (What is dialysis?), intravenous catheter management, mineral supplementation and. Zemplar dosage: . During the same period patient was treated with EPOGEN (View Epogen Review and Epogen Label ), HEPARIN (View Heparin Review and Heparin Label ), VENOFER (View Venofer Review and Venofer Label ).